Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Clinical Pharmacology and Therapeutics|July 1, 1977
Enhancement by food of canrenone bioavailability from spironolactoneA Melander, K Danielson, B Scherstén, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Antihypertensive and renal effects of enalapril and slow-release verapamil in essential hypertension. A double-blind, randomized studyB Fagher, N Henningsen, L Hulthén, et al.
Blood Pressure|July 21, 1999
Selective increase of the contractile response to endothelin-1 in subcutaneous arteries from patients with essential hypertensionH Lind, M Adner, D Erlinge, et al.
European Journal of Pharmacology|February 5, 1999
Endothelial P2Y receptors induce hyperpolarisation of vascular smooth muscle by release of endothelium-derived hyperpolarising factorM Malmsjö, D Erlinge, E D Högestätt, et al.
Acta Physiologica Scandinavica|March 11, 2000
Angiotensin II type 1 receptors stimulate protein synthesis in human cardiac fibroblasts via a Ca2+-sensitive PKC-dependent tyrosine kinase pathwayM Hou, E Pantev, S Möller, et al.
European Journal of Pharmacology|August 10, 1993
Human neuropeptide Y Y1 receptor antisense oligodeoxynucleotide specifically inhibits neuropeptide Y-evoked vasoconstrictionD Erlinge, L Edvinsson, J Brunkwall, et al.
Acta Anaesthesiologica Scandinavica|February 1, 1988
When asleep, one is cooler on beta-blockade than on placebo. A study of pulmonary arterial blood temperature and skeletal muscle heat production in anaesthetized manB Fagher, J Magnússon, M Monti, et al.
Acta Odontologica Scandinavica|June 1, 1993
Office and ambulatory blood pressure in patients with craniomandibular disordersT C de Abreu, M Nilner, T Thulin, et al.
British Journal of Anaesthesia|March 1, 1986
Haemodynamic effects of pretreatment with metoprolol in hypertensive patients undergoing surgeryJ Magnusson, T Thulin, O Werner, et al.
Journal of Cardiovascular Pharmacology|August 13, 1999
Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humansJ H Schwieler, H Ericsson, P Löfdahl, et al.
Pageof 11